Equitable Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
14,048
-194
-1% -$20.1K 0.01% 836
2026
Q1
$1.47M Buy
14,242
+2,960
+26% +$315K 0.01% 847
2025
Q4
$1.16M Sell
11,282
-849
-7% -$82.6K 0.01% 810
2025
Q3
$1.1M Sell
12,131
-2,110
-15% -$185K 0.01% 812
2025
Q2
$1.25M Buy
14,241
+226
+2% +$19.6K 0.01% 731
2025
Q1
$1.28M Sell
14,015
-1,649
-11% -$149K 0.01% 637
2024
Q4
$1.35M Sell
15,664
-8,494
-35% -$768K 0.01% 592
2024
Q3
$2.3M Buy
24,158
+2,221
+10% +$211K 0.02% 455
2024
Q2
$2.01M Buy
21,937
+874
+4% +$78K 0.02% 457
2024
Q1
$1.91M Sell
21,063
-7,072
-25% -$619K 0.02% 455
2023
Q4
$2.29M Buy
28,135
+7,485
+36% +$587K 0.03% 382
2023
Q3
$1.65M Buy
20,650
+10,940
+113% +$882K 0.02% 419
2023
Q2
$765K Buy
9,710
+4,261
+78% +$334K 0.01% 589
2023
Q1
$423K Buy
5,449
+736
+16% +$56.7K 0.01% 687
2022
Q4
$366K Buy
4,713
+1,420
+43% +$105K 0.01% 686
2022
Q3
$221K Buy
3,293
+145
+5% +$10.7K ﹤0.01% 775
2022
Q2
$242K Buy
3,148
+158
+5% +$12.3K ﹤0.01% 759
2022
Q1
$238K Buy
+2,990
New +$229K ﹤0.01% 788

Other funds holding PPH

Equitable Holdings's PPH Position: Q2 2026 in Review

Equitable Holdings reduced its VanEck Pharmaceutical ETF (PPH) stake by 1.4% in Q2 2026, selling an estimated $20.1K and leaving 14,048 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #836.

Equitable Holdings first reported a position in PPH in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.3M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Equitable Holdings held 14,048 shares of VanEck Pharmaceutical ETF worth $1.54M as of Q2 2026.
  • Equitable Holdings sold 194 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $20.1K.
  • VanEck Pharmaceutical ETF made up 0.01% of Equitable Holdings's portfolio in Q2 2026, its #836 holding.
  • Equitable Holdings first reported a position in VanEck Pharmaceutical ETF in Q1 2022 and has held it in 18 quarters since.
  • Equitable Holdings's VanEck Pharmaceutical ETF position peaked at $2.3M in Q3 2024.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.